Prognosis of stage III cervical cancer: a two-way outcome study
Author(s) -
Huihui Zhou,
Qi Li,
Chunyan Xu,
Hong Liang,
Yanan Wang,
Yani Duan,
Min Song,
Yaoxian Wang,
Hong Jin,
Tong Wang
Publication year - 2020
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2020.02.70
Subject(s) - medicine , stage (stratigraphy) , cervical cancer , quality of life (healthcare) , proportional hazards model , oncology , malignancy , cancer , lymph node , paleontology , biology , nursing
With an estimated 570,000 new cases and 311,000 deaths in 2018, cervical cancer is the second most common female malignancy worldwide; 1 in 75 women develop cervical cancer during a lifetime (1). In China, cervical cancer is the second leading cause of cancer death among women, and there were over 102,000 new cases and 30,000 deaths in 2014 (2), making it a major public health problem. Approximately two-thirds of patients in developing countries have locally advanced stage disease at diagnosis, Original Article
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom